About this trial
Crying is a vital communication signal for the baby. Product of a complex physiological process, it reflects not only the organization and functioning of the cortical central nervous system and the function of sympathetic and parasympathetic autonomic regulation but also the integrity of three entities: the lungs responsible for ventilatory mechanics and respiratory rhythm, the larynx and its vocal cords as a phonatory organ, and the oropharyngeal tract guaranteeing the resonance of the sound emitted by the vocal cords.
Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
For a full-term baby > 37 weeks
For a premature baby < 37 weeks
Born in the maternity ward of the Saint-Etienne University Hospital
Holder of parental authority having received informed information about the study and their right to object
Disqualifiers
Refusal of participation by the holder of parental authority
Antenatal pathology, nor perinatal asphyxia
Holder of minor parental authority
Holder of parental authority under curatorship or guardianship
Trial population
Full-term baby \> 37 weeks Premature baby \< 37 weeks
Trial design
Cohort
Prospective
Treatments tested in this trial
Acoustic signal analysis method
Other interventionEvaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.
Treatment groups
Trial outcomes
Primary outcomes
Fundamental frequency f0 (Hz)
Fundamental frequency f0 (Hz) defined from a crying sequence, the most characteristic elementary index of their individual bioacoustic signature.
Bailey-4 quantitative scale
neurodevelopment at age 2 measured by the Bailey-4 quantitative scale. The final score is from 40 (Very weak neurodevelopment) to 160 (Very good neurodevelopment)
Secondary outcomes
Percentage voiced frames
Other bioacoustic characteristics measurable in each bioacoustic sequence
Harmonics of f0 (Hz)
Other bioacoustic characteristics measurable in each bioacoustic sequence : vibration frequency of the vocal cords, defining a +/- low or high tone
Median pitch f0 (Hz)
Other bioacoustic characteristics measurable in each bioacoustic sequence
Harmonicity (dB)
Other bioacoustic characteristics measurable in each bioacoustic sequence
Sponsors and contacts
Click on the lead sponsor to view all of their trials.